| REPH Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the REPH shares outstanding history going back to 3/7/2014:
Also see: REPH Market Cap History REPH YTD Return |
REPH Shares Outstanding History — Recro Pharma Share Count Over Time
As of 2/25/2022 Recro Pharma has 56.42 million REPH shares outstanding. Investors often track the REPH shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows REPH share count trends over time, with 35 historical shares outstanding datapoints presented, dating back to 3/7/2014.
| REPH Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
REPH Historical Shares Outstanding: +32.43% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| REPH Stock Price Chart |
| About Societal CDMO Inc |
| Recro Pharma is a contract development and manufacturing organization, solving formulation and manufacturing challenges primarily in small molecule therapeutic development. Co. utilizes its formulation and development knowledge to develop and manufacture pharmaceutical products using proprietary delivery technologies and know-how for partners who develop and commercialize or plan to commercialize these products. Co. has launched its clinical trials support services capabilities, which includes preparation of clinical trial supplies, as well as services dedicated to the development and Good Manufacturing Practices, of high-potency products. We show 35 historical shares outstanding datapoints in our coverage of REPH's shares outstanding history. Understanding the changing numbers of REPH shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like REPH versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching REPH by allowing them to research REPH shares outstanding history as well as any other stock in our coverage universe. |
| REPH Current Stock Quote |
Quotes delayed 20 minutes  Free REPH Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| REPH Share Performance |
| Shares Outstanding Peers |
| Recro Pharma (REPH) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
REPL Shares Outstanding History REPR Shares Outstanding History RETA Shares Outstanding History REXN Shares Outstanding History RGEN Shares Outstanding History RGLS Shares Outstanding History RGNX Shares Outstanding History RIGL Shares Outstanding History RLAY Shares Outstanding History RLMD Shares Outstanding History More Healthcare companies » |
REPH Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
